Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PORMÁS is a line of sports nutritional supplements developed by the Centro Nacional de Biopreparados (BioCen) in Cuba, in collaboration with Cubadeportes S.A. and the Instituto de Medicina Deportiva. This specific product line includes formulations such as 'Más Proteína' (whey protein) and 'Más Glutamina' (glutamine), designed to support muscle mass gain and enhance recovery following intense physical exertion. Whey protein serves as a high-quality protein source to stimulate muscle protein synthesis, while glutamine acts as an anti-catabolic agent to protect muscle tissue. Primarily intended for high-performance athletes, bodybuilders, and dancers, PORMÁS is the first domestically manufactured supplement of its kind in Cuba, aimed at substituting imports and meeting the specific physiological demands of athletes. The products are certified by Cuba's Instituto Nacional de Higiene, Epidemiología y Microbiología (INHEM) and validated by the Cuban Anti-Doping Laboratory.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PORMÁS.